ArticleEvaluation of CD4+CD25+ regulatory T cells in patients with hepatocellular carcinoma and liver cirrhosis
ArticleEvaluation of CD4+CD25+ regulatory T cells in patients with hepatocellular carcinoma and liver cirrhosis
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleAssessment of CD4+CD25+ Regulatory T Lymphocytes Cells in Chronic Hepatitis C, Chronic Hepatitis C– Associated Cirrhosis and Hepatocellular Carcinoma Patients
ArticleAssessment of CD4+CD25+ Regulatory T Lymphocytes Cells in Chronic Hepatitis C, Chronic Hepatitis C– Associated Cirrhosis and Hepatocellular Carcinoma Patients
ArticleREGULATION OF CELLULAR IMMUNE RESPONSE BY NATURALLY OCCURRING PRODUCTS ON HEPATOCELLULAR CARCINOMA
ArticleREGULATION OF CELLULAR IMMUNE RESPONSE BY NATURALLY OCCURRING PRODUCTS ON HEPATOCELLULAR CARCINOMA
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleHigh expression of the checkpoint molecule PD-1 on conventional CD4+ and regulatory T cells in the peripheral blood of Hepatocellular carcinoma patients
ArticleValue of Hypermethylation (RASSF1A) Promoter Gene among Patients with Hepatocellular Carcinoma
ArticleValue of Hypermethylation (RASSF1A) Promoter Gene among Patients with Hepatocellular Carcinoma